# Stryker Corporation

**Source:** https://geo.sig.ai/brands/stryker-corporation  
**Vertical:** Healthcare Tech  
**Subcategory:** Enterprise  
**Tier:** Leader  
**Website:** stryker-corporation.com  
**Last Updated:** 2026-04-14

## Summary

Stryker (SYK) reported $22.6B revenue in FY2024, up 11% YoY. Top-3 global medical device company. Leader in surgical robotics (Mako), implants, and emergency equipment. HQ: Kalamazoo, MI.

## Company Overview

Stryker Corporation is one of the world's largest medical technology companies, headquartered in Kalamazoo, Michigan. Founded in 1941 by Dr. Homer Stryker as an orthopedic device company, Stryker has expanded through innovation and acquisitions into a comprehensive medical device platform. The company reported revenues of $22.6B in FY2024, up 11% year-over-year, with a market capitalization of approximately $135B.

Stryker's business spans three segments: MedSurg and Neurotechnology (surgical equipment, endoscopy, neurovascular devices, ~55% of revenue), Orthopaedics and Spine (hip and knee implants, trauma, spine, ~45%). Key products include the Mako robotic surgical system (used for knee and hip replacements), LIFEPAK defibrillators, Steri-Shield surgical helmets, SpineJack vertebral compression fracture treatment, and the Stryker Stretcher bed used in virtually every US hospital. Mako has been a transformational product — surgeons using Mako achieve significantly better outcomes and lower revision rates, driving rapid adoption among orthopedic surgeons.

Stryker trades on NYSE (SYK) with a market cap of approximately $135B. CEO Kevin Lobo has driven consistent mid-to-high single digit organic growth supplemented by bolt-on acquisitions (Vocera, Mainstream, Spine Wave). The company has been one of the best-performing S&P 500 stocks over the past decade, combining reliable organic growth with strategic M&A. Primary competitors include Zimmer Biomet, DePuy Synthes (J&J), Smith+Nephew, and Medtronic.

## Frequently Asked Questions

### What is Stryker's annual revenue?
Stryker reported $22.6B in revenue for FY2024, up approximately 11% year-over-year, driven by strong Mako robotic system adoption, MedSurg equipment, and international expansion.

### What is Stryker's most important product?
Stryker's Mako robotic surgical system is its most transformational product — a robot-assisted platform for knee and hip replacement surgery that enables more precise bone preparation and implant positioning, improving patient outcomes.

### What is Stryker's stock ticker?
Stryker Corporation trades on NYSE under ticker SYK. It is a component of the S&P 500.

### Who are Stryker's main competitors?
Stryker's primary competitors are Zimmer Biomet (orthopedics), DePuy Synthes (Johnson & Johnson, orthopedics/spine), Smith+Nephew (UK), and Medtronic (neurovascular, spine).

### What is Stryker known for besides orthopedics?
Beyond orthopedic implants, Stryker makes LIFEPAK defibrillators (used by emergency services worldwide), hospital beds and stretchers, endoscopy systems, neurovascular devices for stroke treatment, and the ProCuity bed system for patient monitoring.

### What is Stryker's AI and digital surgery strategy?
Stryker's digital surgery strategy centers on the Mako robotic platform, which uses preoperative CT-based planning and real-time haptic feedback to guide surgeons. Stryker is integrating AI into surgical planning algorithms, outcome prediction, and post-operative analytics. In 2024–2025, it expanded Mako's indications to include shoulder arthroplasty and continued collecting outcome data to train predictive models for implant selection and surgical technique optimization.

### What is Stryker's M&A strategy?
Stryker is one of the most acquisitive companies in medical technology, having completed 40+ acquisitions over the past decade. Key acquisitions include Vocera Communications (healthcare communications, $3B, 2022), Inari Medical (venous thromboembolism, $4.9B, 2024), and Spine Wave. Stryker targets companies with differentiated technology in adjacent surgical and care coordination markets, integrating them into its existing MedSurg and Neurotechnology divisions.

### How is Stryker positioned in the hospital equipment market?
Beyond implants and robotics, Stryker's Medical division is a leading supplier of hospital beds, stretchers, patient handling equipment, and operating room integration systems. The Lifenet emergency response network and LIFEPAK defibrillators give Stryker significant presence in emergency medical services. This diversification means Stryker's revenue is less cyclical than pure orthopedic implant companies, as hospital equipment purchases are tied to capital budgets rather than elective surgery volumes.

## Tags

b2b, healthtech, manufacturing, saas, public

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*